In addition, interestingly, while some basic scientific studies proposed the benefits of ASA, NSAIDs, and even cilostazol in TB treatment, there are no such studies so far that highlighted ADP receptor antagonists as a potential adjunct anti-TB treatment [29,30,31]. Here, P2RY1 is linked to tuberculosis.